Tag Archives: BIO International Convention

Industry-Disease Foundation Partnerships Thrive on Communication & Transparency

Attendees

Disease foundations are playing an increasingly important role in advancing research and helping to bring new treatments to market. Their unique expertise in specific disease areas, along with their keen understanding of patient needs and access to clinical thought leaders and patients, can enhance and accelerate the clinical development of new treatments. At a 2014 BIO International Convention Breakout Session, session moderator Gail Maderis, President and CEO of BayBio, opened with some key statistics about Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Turning Urban Waste into Bioplastic

lab_tech

Bacteria possible key to produce useful bioplastics from the gasification of urban waste Each year, the European Union produces three billion tonnes of waste. According to Eurostat (the statistical office of the European Union), this equates to six tonnes of solid waste for every EU citizen. A major challenge is finding ways to reduce and reuse a large amount of this waste. But now, the EU funded Synpol Project, which aims to propel the sustainable Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Why We Do This Work

rachel-king

In her keynote remarks delivered yesterday at the 2014 BIO International Convention, Rachel King, president & CEO of GlycoMimetics and chairperson of the board of the Biotechnology Industry Organization (BIO), talked about why entrepreneurs pursue opportunities in biotechnology and what sustains these industry leaders through the rollercoaster of raising money, clinical trials, road shows and all the ups and downs of bringing medical innovations from the lab to the bedside. “Working in biotechnology today, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Seeing is Believing

brain-scan

PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure of new drug programs is a major source of concern, with failure rates ranging from 75 percent in anti-infectives to 92 percent in CNS according to DiMasi’s 2010 study (Clin. Pharmacol. Ther. 87, 272-277). Molecular imaging – both Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) can help improve these dismal statistics. Given the immense costs involved in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

A Better Way to Make Unnatural Amino Acids Discovered by Yu

Make Unnatural Amino Acids

Certain amino acids that are not found in nature are highly sought after by pharmaceutical manufacturers. These “unnatural” amino acids have traditionally been very difficult to synthesize, so a new and improved technique for doing so is attracting a lot of attention. Amino acids are among the most basic components of living things. Long chains of them, translated from DNA, fold up to become proteins, some smaller groupings of amino acids form hormones, and a Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,